Compare Amylx Pharmaceuticals Inc (AMLX) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Royal Caribbean Cruises Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Royal Caribbean Cruises Ltd trades at $308 (market cap $82.15B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 31.1× Amylx Pharmaceuticals Inc's market cap, and Royal Caribbean Cruises Ltd pays a 1.63% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | RCL | |
|---|---|---|
Market Cap | $2.64B | $82.15B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $365.84 |
52-Week Low | $7.82 | $246.71 |
Enterprise Value | $2.39B | $104.79B |
Dividend Yield | — | 1.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
